Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
W.W. Grainger heads into its November 4 earnings date with a stock that has gained nearly 4% on the week, yet with short sellers adding positions at a pace that stands out in an otherwise low-conviction name.
The most notable tension right now is not in the price action but underneath it. Short interest has climbed 24% in a week and almost 39% over the past month, reaching 2.8% of the free float. That remains a low absolute level, and the borrow market is extraordinarily relaxed: availability is above 4,700%, meaning there are roughly 47 shares available to borrow for every one currently borrowed. Cost to borrow has also risen, up 44% over the week to 0.61%, but that is still a negligible carry for anyone holding a short position. The story here is not a squeeze setup or a constrained borrow market. It is a gradual, deliberate accumulation of short interest in a stock that has been a consistent outperformer. The ORTEX short score edged up from the mid-35s to 38.2 over the past week, a modest but directional move that tracks the positioning shift. Options confirm the market is not particularly agitated: the put/call ratio at 0.69 is essentially flat against its 20-day average of 0.69 and well below the 52-week high of 0.71. Investors are not rushing to buy downside protection.
The Street gives the stock a mixed-but-leaning-neutral read. Most analysts who have moved recently have trimmed targets rather than changed their rating. RBC Capital lowered its target by a token $1 to $1,427 this week while staying at Sector Perform, and Barclays repeated a similar trim last month, cutting to $1,172 from $1,185 on an Underweight. Morgan Stanley, also maintaining Equal-Weight, raised its target to $1,400 in August. The mean target across the Street sits at $1,332, almost exactly where the stock is trading now at $1,325, which itself tells the story: the consensus sees little incremental upside from current levels. That is reinforced by forward earnings growth standing in the 98th percentile of all stocks tracked by ORTEX, yet the PE at 26.5 and EV/EBITDA near 18 reflect a stock that has already priced much of that growth in. The analyst recommendation differential score of 93 points to Grainger having more positive coverage relative to peers, but most of that optimism is reflected in the price.
The bull-bear debate ahead of the November print is reasonably well-defined. Bears note that the Q2 earnings beat was flattered by approximately $43 million in tariff refunds, and that core gross margin of 38.6% still missed consensus. All-in gross margin guidance for the full year runs at 39.3% to 39.6%, leaving limited room for upside surprise on profitability. Product mix, freight and fuel costs continue to absorb pricing actions, and any softening in industrial demand would hit the High-Touch segment at the same moment that the Endless Assortment business requires continued SG&A investment to sustain its growth trajectory. Bulls counter with market share gains of roughly 400 basis points over 2023 to 2025 and 750 basis points in Q1 2026, a MonotaRO business growing above 15% annually, and July organic average daily sales growth of around 13%. The divergence is essentially about whether those share gains can continue to offset margin headwinds.
Institutional ownership is broadly passive and steady. BlackRock holds 9.8% with a small add in the most recent period, Geode Capital added 139,151 shares as of end-September, and State Street added 14,900. None of that is particularly active conviction. The only insider activity in the past 90 days is a grant of 590 shares to the Interim CFO in October, a compensation event rather than a market signal.
The next hard catalyst is the November 4 earnings release. The last print sent the stock down 6.3% on the day and 5.1% over the following week. With short interest building into that event, the size of the short position relative to float is still too small to create meaningful mechanical pressure in either direction, but the pace of accumulation over the past month, nearly 40%, suggests that a subset of investors are positioning for a repeat of the August disappointment rather than a beat.
See the live data behind this article on ORTEX.
Open GWW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
